Specific serum ig recognizing staphylococcal wall teichoic acid induces complement-mediated opsonophagocytosis against staphylococcus aureus

Journal of Immunology

Volumn 189, Issue 10, 2012, Pages 4951-4959

  Jung, Dong Jun ^a   An, Jang Hyun ^a   Kurokawa, Kenji ^a   Jung, Yoon Chuel ^b   Kim, Min Jung ^a   Aoyagi, Youko ^c   Matsushita, Misao ^d   Takahashi, Shinji ^c   Lee, Hee Seung ^b   Takahashi, Kazue ^e   Lee, Bok Luel ^a  

^a Pusan National University   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^c Joshi Eiyoh University   (Japan)

^d TOKAI UNIVERSITY   (Japan)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN G ANTIBODY; TEICHOIC ACID;

ADAPTIVE IMMUNITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL STRAIN; BINDING AFFINITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOGLOBULIN BLOOD LEVEL; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PURIFICATION; STAPHYLOCOCCUS AUREUS;

ADULT; ANTIBODIES, BACTERIAL; ANTIGEN-ANTIBODY COMPLEX; CELL WALL; COMPLEMENT C3; COMPLEMENT C4; COMPLEMENT PATHWAY, CLASSICAL; HUMANS; IMMUNOGLOBULIN G; NEUTROPHILS; PHAGOCYTOSIS; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS;

EID: 84868524290     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201294     Document Type: Article

References (47)

1. Walport, M. J. 2001. Complement. First of two parts. N. Engl. J. Med. 344: 1058-1066.
2. Ricklin, D., G. Hajishengallis, K. Yang, and J. D. Lambris. 2010. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11: 785-797.
3. Daha, N. A., N. K. Banda, A. Roos, F. J. Beurskens, J. M. Bakker, M. R. Daha, and L. A. Trouw. 2011. Complement activation by (auto-) antibodies. Mol. Immunol. 48: 1656-1665.
4. Fujita, T. 2002. Evolution of the lectin-complement pathway and its role in innate immunity. Nat. Rev. Immunol. 2: 346-353.
5. Walport, M. J. 2001. Complement. Second of two parts. N. Engl. J. Med. 344: 1140-1144.
6. Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532.
7. Weidenmaier, C., and A. Peschel. 2008. Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat. Rev. Microbiol. 6: 276-287.
8. Xia, G., T. Kohler, and A. Peschel. 2010. The wall teichoic acid and lipoteichoic acid polymers of Staphylococcus aureus. Int. J. Med. Microbiol. 300: 148-154.
9. Weidenmaier, C., J. F. Kokai-Kun, S. A. Kristian, T. Chanturiya, H. Kalbacher, M. Gross, G. Nicholson, B. Neumeister, J. J. Mond, and A. Peschel. 2004. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat. Med. 10: 243-245.
10. Gründling, A., and O. Schneewind. 2007. Synthesis of glycerol phosphate lipo-teichoic acid in Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 104: 8478-8483.
11. Oku, Y., K. Kurokawa, M. Matsuo, S. Yamada, B. L. Lee, and K. Sekimizu. 2009. Pleiotropic roles of polyglycerolphosphate synthase of lipoteichoic acid in growth of Staphylococcus aureus cells. J. Bacteriol. 191: 141-151.
12. Park, K. H., K. Kurokawa, L. Zheng, D. J. Jung, K. Tateishi, J. O. Jin, N. C. Ha, H. J. Kang, M. Matsushita, J. Y. Kwak, et al. 2010. Human serum mannose-binding lectin senses wall teichoic acid Glycopolymer of Staphylococcus aureus, which is restricted in infancy. J. Biol. Chem. 285: 27167-27175.
13. Matsuo, M., K. Kurokawa, B. L. Lee, and K. Sekimizu. 2010. Shuttle vectors derived from pN315 for study of essential genes in Staphylococcus aureus. Biol. Pharm. Bull. 33: 198-203.
14. Stoll, H., J. Dengjel, C. Nerz, and F. Götz. 2005. Staphylococcus aureus deficient in lipidation of prelipoproteins is attenuated in growth and immune activation. Infect. Immun. 73: 2411-2423.
15. Shiratsuchi, A., K. Shimizu, I. Watanabe, Y. Hashimoto, K. Kurokawa, I. M. Razanajatovo, K. H. Park, H. K. Park, B. L. Lee, K. Sekimizu, and Y. Nakanishi. 2010. Auxiliary role for D-alanylated wall teichoic acid in Tolllike receptor 2-mediated survival of Staphylococcus aureus in macrophages. Immunology 129: 268-277.
16. Rosenthal, R. S., and R. Dziarski. 1994. Isolation of peptidoglycan and soluble peptidoglycan fragments. Methods Enzymol. 235: 253-285.
17. Jang, K. S., J. E. Baik, S. S. Kang, J. H. Jeon, S. Choi, Y. H. Yang, B. G. Kim, C. H. Yun, and S. H. Han. 2012. Identification of staphylococcal lipoteichoic acid-binding proteins in human serum by high-resolution LTQ-Orbitrap mass spectrometry. Mol. Immunol. 50: 177-183.
18. Kang, H. J., S. M. Lee, H. H. Lee, J. Y. Kim, B. C. Lee, J. S. Yum, H. M. Moon, and B. L. Lee. 2007. Mannose-binding lectin without the aid of its associated serine proteases alters lipopolysaccharide-mediated cytokine/chemokine secretion from human endothelial cells. Immunology 122: 335-342.
19. Kolb, H. C., M. G. Finn, and K. B. Sharpless. 2001. Click chemistry: diverse chemical function from a few good reactions. Angew. Chem. Int. Ed. Engl. 40: 2004-2021.
20. Aoyagi, Y., E. E. Adderson, J. G. Min, M. Matsushita, T. Fujita, S. Takahashi, Y. Okuwaki, and J. F. Bohnsack. 2005. Role of L-ficolin/mannose- binding lectin-associated serine protease complexes in the opsonophagocytosis of type III group B streptococci. J. Immunol. 174: 418-425.
21. Nimmerjahn, F., and J. V. Ravetch. 2008. Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 8: 34-47.
22. Navarre, W. W., and O. Schneewind. 1999. Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol. Mol. Biol. Rev. 63: 174-229.
23. Tabuchi, Y., A. Shiratsuchi, K. Kurokawa, J. H. Gong, K. Sekimizu, B. L. Lee, and Y. Nakanishi. 2010. Inhibitory role for D-alanylation of wall teichoic acid in activation of insect Toll pathway by peptidoglycan of Staphylococcus aureus. J. Immunol. 185: 2424-2431.
24. Joiner, K. A., E. J. Brown, and M. M. Frank. 1984. Complement and bacteria: chemistry and biology in host defense. Annu. Rev. Immunol. 2: 461-491.
25. Brüggemann, M., G. T. Williams, C. I. Bindon, M. R. Clark, M. R. Walker, R. Jefferis, H. Waldmann, and M. S. Neuberger. 1987. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J. Exp. Med. 166: 1351-1361.
26. Bindon, C. I., G. Hale, M. Brüggemann, and H. Waldmann. 1988. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q. J. Exp. Med. 168: 127-142.
27. Dangl, J. L., T. G. Wensel, S. L. Morrison, L. Stryer, L. A. Herzenberg, and V. T. Oi. 1988. Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J. 7: 1989-1994.
28. Verbrugh, H. A., R. Peters, P. K. Peterson, and J. Verhoef. 1978. Phagocytosis and killing of staphylococci by human polymorphonuclear and mononuclear leucocytes. J. Clin. Pathol. 31: 539-545.
29. Peterson, P. K., Y. Kim, B. J. Wilkinson, D. Schmeling, A. F. Michael, and P. G. Quie. 1978. Dichotomy between opsonization and serum complement activation by encapsulated staphylococci. Infect. Immun. 20: 770-775.
30. Peterson, P. K., B. J. Wilkinson, Y. Kim, D. Schmeling, and P. G. Quie. 1978. Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Infect. Immun. 19: 943-949.
31. Verbrugh, H. A., P. K. Peterson, B. Y. Nguyen, S. P. Sisson, and Y. Kim. 1982. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement. J. Immunol. 129: 1681-1687.
32. Neth, O., D. L. Jack, A. W. Dodds, H. Holzel, N. J. Klein, and M. W. Turner. 2000. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect. Immun. 68: 688-693.
33. Neth, O., D. L. Jack, M. Johnson, N. J. Klein, and M. W. Turner. 2002. Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus. J. Immunol. 169: 4430-4436.
34. Eisen, D. P., M. M. Dean, M. A. Boermeester, K. J. Fidler, A. C. Gordon, G. Kronborg, J. F. Kun, Y. L. Lau, A. Payeras, H. Valdimarsson, et al. 2008. Low serum mannose-binding lectin level increases the risk of death due to pneumo-coccal infection. Clin. Infect. Dis. 47: 510-516.
35. Smithson, A., R. Perelló, J. P. Horcajada, J. M. Nicolas, and F. Lozano. 2008. Is mannose-binding lectin deficiency associated with infection due to Gram-positive bacteria? Clin. Infect. Dis. 47: 1492-1493, author reply 1493.
36. Super, M., S. Thiel, J. Lu, R. J. Levinsky, and M. W. Turner. 1989. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 2: 1236-1239.
37. Summerfield, J. A., M. Sumiya, M. Levin, and M. W. Turner. 1997. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ 314: 1229-1232.
38. Koch, A., M. Melbye, P. Sørensen, P. Homøe, H. O. Madsen, K. Mølbak, C. H. Hansen, L. H. Andersen, G. W. Hahn, and P. Garred. 2001. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA 285: 1316-1321.
39. Christensson, B., F. J. Fehrenbach, and S. A. Hedström. 1985. A new serological assay for Staphylococcus aureus infections: detection of IgG antibodies to S. aureus lipase with an enzyme-linked immunosorbent assay. J. Infect. Dis. 152: 286-292.
40. Colque-Navarro, P., B. Söderquist, H. Holmberg, L. Blomqvist, P. Olcén, and R. Möllby. 1998. Antibody response in Staphylococcus aureus septicaemia\a prospective study. J. Med. Microbiol. 47: 217-225.
41. Dryla, A., S. Prustomersky, D. Gelbmann, M. Hanner, E. Bettinger, B. Kocsis, T. Kustos, T. Henics, A. Meinke, and E. Nagy. 2005. Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. Clin. Diagn. Lab. Immunol. 12: 387-398.
42. Wertheim, H. F., E. Walsh, R. Choudhurry, D. C. Melles, H. A. Boelens, H. Miajlovic, H. A. Verbrugh, T. Foster, and A. van Belkum. 2008. Key role for clumping factor B in Staphylococcus aureus nasal colonization of humans. PLoS Med. 5: e17.
43. Colque-Navarro, P., G. Jacobsson, R. Andersson, J. I. Flock, and R. Möllby. 2010. Levels of antibody against 11 Staphylococcus aureus antigens in a healthy population. Clin. Vaccine Immunol. 17: 1117-1123.
44. Lagos, R., A. Munoz, M. M. Levine, W. Watson, I. Chang, and P. Paradiso. 2009. Immunology of combining CRM(197) conjugates for Streptococcus pneumoniae, Neisseria meningitis and Haemophilus influenzae in Chilean infants. Vaccine 27: 2299-2305.
45. Fattom, A., S. Fuller, M. Propst, S. Winston, L. Muenz, D. He, R. Naso, and G. Horwith. 2004. Safety and immunogenicity of a booster dose of Staphylo-coccus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients. Vaccine 23: 656-663.
46. Novick, R. P., H. F. Ross, S. J. Projan, J. Kornblum, B. Kreiswirth, and S. Moghazeh. 1993. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J. 12: 3967-3975.
47. Kaito, C., and K. Sekimizu. 2007. Colony spreading in Staphylococcus aureus. J. Bacteriol. 189: 2553-2557.